BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20953661)

  • 1. Expression of Gli1 and PARP1 in medulloblastoma: an immunohistochemical study of 65 cases.
    Pizem J; Popovic M; Cör A
    J Neurooncol; 2011 Jul; 103(3):459-67. PubMed ID: 20953661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
    Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ
    Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma.
    Al-Halabi H; Nantel A; Klekner A; Guiot MC; Albrecht S; Hauser P; Garami M; Bognar L; Kavan P; Gerges N; Shirinian M; Roberge D; Muanza T; Jabado N
    Acta Neuropathol; 2011 Feb; 121(2):229-39. PubMed ID: 21107850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1.
    Salsano E; Croci L; Maderna E; Lupo L; Pollo B; Giordana MT; Consalez GG; Finocchiaro G
    Neuro Oncol; 2007 Jul; 9(3):298-307. PubMed ID: 17522332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
    Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD
    Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
    Ellison DW; Onilude OE; Lindsey JC; Lusher ME; Weston CL; Taylor RE; Pearson AD; Clifford SC;
    J Clin Oncol; 2005 Nov; 23(31):7951-7. PubMed ID: 16258095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
    D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired box gene 8 (PAX8) expression is associated with sonic hedgehog (SHH)/wingless int (WNT) subtypes, desmoplastic histology and patient survival in human medulloblastomas.
    Harter PN; Baumgarten P; Zinke J; Schilling K; Baader S; Hartmetz AK; Schittenhelm J; Beschorner R; Liebner S; Schulte D; Plate KH; Gutwein P; Korshunov A; Pfister SM; Jones DT; Doberstein K; Mittelbronn M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):165-79. PubMed ID: 25287489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1.
    Weiner HL; Bakst R; Hurlbert MS; Ruggiero J; Ahn E; Lee WS; Stephen D; Zagzag D; Joyner AL; Turnbull DH
    Cancer Res; 2002 Nov; 62(22):6385-9. PubMed ID: 12438220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes.
    Yoon JW; Gilbertson R; Iannaccone S; Iannaccone P; Walterhouse D
    Int J Cancer; 2009 Jan; 124(1):109-19. PubMed ID: 18924150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma.
    Zinke J; Schneider FT; Harter PN; Thom S; Ziegler N; Toftgård R; Plate KH; Liebner S
    Mol Cancer; 2015 Feb; 14(1):17. PubMed ID: 25645196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.
    Łastowska M; Jurkiewicz E; Trubicka J; Daszkiewicz P; Drogosiewicz M; Malczyk K; Grajkowska W; Matyja E; Cukrowska B; Pronicki M; Perek-Polnik M; Perek D; Dembowska-Bagińska B
    J Neurooncol; 2015 May; 123(1):65-73. PubMed ID: 25862008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential activation of Snail1 and N-Myc modulates sonic hedgehog-induced transformation of neural cells.
    Colvin Wanshura LE; Galvin KE; Ye H; Fernandez-Zapico ME; Wetmore C
    Cancer Res; 2011 Aug; 71(15):5336-45. PubMed ID: 21646478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma.
    Shahi MH; Afzal M; Sinha S; Eberhart CG; Rey JA; Fan X; Castresana JS
    BMC Cancer; 2010 Nov; 10():614. PubMed ID: 21059263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.
    Fernandez-L A; Northcott PA; Dalton J; Fraga C; Ellison D; Angers S; Taylor MD; Kenney AM
    Genes Dev; 2009 Dec; 23(23):2729-41. PubMed ID: 19952108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin is a negative prognostic marker in medulloblastoma.
    Pizem J; Cört A; Zadravec-Zaletel L; Popovic M
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry.
    Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R
    J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLI2 is a potential therapeutic target in pediatric medulloblastoma.
    Buczkowicz P; Ma J; Hawkins C
    J Neuropathol Exp Neurol; 2011 Jun; 70(6):430-7. PubMed ID: 21572341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
    Zhukova N; Ramaswamy V; Remke M; Pfaff E; Shih DJ; Martin DC; Castelo-Branco P; Baskin B; Ray PN; Bouffet E; von Bueren AO; Jones DT; Northcott PA; Kool M; Sturm D; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognar L; Klekner A; Cho BK; Kim SK; Wang KC; Eberhart CG; Fevre-Montange M; Fouladi M; French PJ; Kros M; Grajkowska WA; Gupta N; Weiss WA; Hauser P; Jabado N; Jouvet A; Jung S; Kumabe T; Lach B; Leonard JR; Rubin JB; Liau LM; Massimi L; Pollack IF; Shin Ra Y; Van Meir EG; Zitterbart K; Schüller U; Hill RM; Lindsey JC; Schwalbe EC; Bailey S; Ellison DW; Hawkins C; Malkin D; Clifford SC; Korshunov A; Pfister S; Taylor MD; Tabori U
    J Clin Oncol; 2013 Aug; 31(23):2927-35. PubMed ID: 23835706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma.
    Natsumeda M; Miyahara H; Yoshimura J; Nakata S; Nozawa T; Ito J; Kanemaru Y; Watanabe J; Tsukamoto Y; Okada M; Oishi M; Hirato J; Wataya T; Ahsan S; Tateishi K; Yamamoto T; Rodriguez FJ; Takahashi H; Hovestadt V; Suva ML; Taylor MD; Eberhart CG; Fujii Y; Kakita A
    J Neuropathol Exp Neurol; 2021 Jan; 80(2):129-136. PubMed ID: 33249504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.